In addition, we believe the Board's implementation of the «poison pill» serves no purpose other than to keep BVF from purchasing
additional stock in the Company.
In addition, we believe the Board's implementation of the stockholder rights plan, or «poison pill,» serves no purpose other than to entrench the Board and keep the BVF Group from purchasing
additional stock in the Company.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected
in such forward - looking statements and that should be considered
in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for
additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases
in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest
in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions
in the industries and markets
in which we operate
in the U.S. and globally and any changes therein, including fluctuations
in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain
in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with
additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow
additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both
in the U.S. and abroad; 20) the effect of changes
in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the
Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction
in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our
additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco
in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations
in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated
stock repurchase plan, among other things.
On the other end of the spectrum, Apple Inc shares rose 4.4 percent after the
company late Tuesday posted resilient iPhone sales
in the face of waning global demand and promised $ 100 billion
in additional stock buybacks.
As previously announced, the
company issued an
additional $ 34.5 million of 5.25 % Class M cumulative redeemable preferred
stock after the underwriters exercised their 30 - day over-allotment option
in January of 2018.
Pursuant to the offering, Centene granted the underwriters an option to purchase from the
Company up to an
additional $ 260 million
in shares of common
stock.
The
stock has benefited from increases
in both tourism and business journeys, and it got an
additional jolt this fall when it announced plans to split into three
companies, spinning off its timeshare units and its Park Hotels & Resorts division.
One final thing to notice is: while family and friends will take common
stock from your
company in exchange for their hard - earned money, professional investors will most often look for some kind of
additional benefit.
As of September 26, 2015, an
additional 179,211 shares of Apple's common
stock were subject to outstanding
stock options assumed
in connection with acquisitions of other
companies (with a weighted - average exercise price of $ 6.17 per share).
(l) Except as otherwise set forth
in Schedule 2.7 (l) of the Disclosure Schedule, (i) the
Company is not and will not be obligated to pay separation, severance, termination or similar benefits as a result of any of the transactions contemplated by this Agreement, nor will any such transactions accelerate the time of payment or vesting, or increase the amount, of any benefit or other compensation due to any individual; and (ii) the transactions contemplated by this Agreement will not cause the
Company to record
additional compensation expense on its income statements with respect to any outstanding
Stock Option or other equity - based award.
Additional information about the LTICP and other plans pursuant to which awards
in the form of shares of the
Company's common
stock may be made to directors and employees
in exchange for goods or services is provided under «Equity Compensation Plan Information.»
If we raise
additional funds through further issuances of equity, convertible debt securities, or other securities convertible into equity, our existing stockholders could suffer significant dilution
in their percentage ownership of our
company, and any new equity securities we issue could have rights, preferences, and privileges senior to those of holders of our Class A common
stock.
In the event the Company issues shares of additional stock, subject to customary exceptions, after the preferred stock original issue date without consideration or for a consideration per share less than the initial conversion price in effect immediately prior to such issuance, then and in each such event the conversion price shall be reduced to a price equal to such conversion price multiplied by the following fractio
In the event the
Company issues shares of
additional stock, subject to customary exceptions, after the preferred
stock original issue date without consideration or for a consideration per share less than the initial conversion price
in effect immediately prior to such issuance, then and in each such event the conversion price shall be reduced to a price equal to such conversion price multiplied by the following fractio
in effect immediately prior to such issuance, then and
in each such event the conversion price shall be reduced to a price equal to such conversion price multiplied by the following fractio
in each such event the conversion price shall be reduced to a price equal to such conversion price multiplied by the following fraction:
creation of
additional shares of Series C convertible preferred
stock; or (iii) effect a change of control, liquidation, dissolution, or winding up of the
Company in which the holders of Series C convertible preferred
stock would receive an amount per share less than the original issue price plus any declared but unpaid dividends on such shares of Series C convertible preferred
stock.
Pursuant to the policy, as revised
in February 2009, at each annual meeting of our stockholders, provided that the director has served on the Board for at least six months prior to the annual meeting, a non-employee director would be granted RSUs having a value equal to $ 225,000 divided by the lesser of (i) the trailing average closing trading prices of our common
stock for the 180 - day period preceding and ending with the date of the RSU grant or (ii) such number of RSUs as the Board may determine based on
additional criteria such as business conditions and / or
company performance, outside director compensation practices at peer
companies and advice from outside compensation consultants.
In connection with the acquisition of XA Secure, the
Company also issued 265,012 shares of restricted
stock, issued 318,966 options to purchase the
Company's common
stock and may be required to pay an
additional $ 3.92 million to certain key employee - shareholders of XA Secure.
In the United States last year, close to 20 percent of private - sector employees owned stock, and 7 percent held stock options, in the companies where they worked, while about one - third participated in some kind of cash profit - sharing and one - fourth in gain - sharing (when workers get additional compensation based on improvement on a metric other than profits, like sales or customer satisfaction
In the United States last year, close to 20 percent of private - sector employees owned
stock, and 7 percent held
stock options,
in the companies where they worked, while about one - third participated in some kind of cash profit - sharing and one - fourth in gain - sharing (when workers get additional compensation based on improvement on a metric other than profits, like sales or customer satisfaction
in the
companies where they worked, while about one - third participated
in some kind of cash profit - sharing and one - fourth in gain - sharing (when workers get additional compensation based on improvement on a metric other than profits, like sales or customer satisfaction
in some kind of cash profit - sharing and one - fourth
in gain - sharing (when workers get additional compensation based on improvement on a metric other than profits, like sales or customer satisfaction
in gain - sharing (when workers get
additional compensation based on improvement on a metric other than profits, like sales or customer satisfaction).
The
Company's board of directors also approved an
additional distribution to its members, to the extent the gross proceeds of the
Company's planned initial public offering exceed the anticipated gross proceeds (including as a result of the exercise by the underwriters of their option to purchase
additional shares of Class A common
stock),
in an amount equal to the product of (A) the increased gross proceeds and (B) 0.273, to be paid from the proceeds of the
Company's planned initial public offering.
In addition, the pro forma stockholders» equity assumes the reclassification of the redeemable convertible preferred stock warrant liability to additional paid - in capital upon a qualifying IPO of the Company's common stock, assuming the redeemable convertible preferred stock warrants automatically become common stock warrants that are classified as equity and are not subject to remeasuremen
In addition, the pro forma stockholders» equity assumes the reclassification of the redeemable convertible preferred
stock warrant liability to
additional paid -
in capital upon a qualifying IPO of the Company's common stock, assuming the redeemable convertible preferred stock warrants automatically become common stock warrants that are classified as equity and are not subject to remeasuremen
in capital upon a qualifying IPO of the
Company's common
stock, assuming the redeemable convertible preferred
stock warrants automatically become common
stock warrants that are classified as equity and are not subject to remeasurement.
You'd think that corporate debt would grow
in proportion to total sales, as this
additional debt is used to fund investments
in productive activities that create more sales and contribute to the economy, and that higher sales, and presumably higher earnings would create a proportionate increase
in the value of the
company, and thus
in its
stock price, and that they all go up together, not
in lockstep but over time more or less at the same rate.
In addition, based on the fair value of the shares of common
stock of the
Company at the time of issuance, the
Company recorded an
additional $ 100,000 of share based compensation expense related to the transaction.
QS Investors LLC now owns 75,620 shares of the biopharmaceutical
company's
stock worth $ 2,358,000 after purchasing an
additional 3,771 shares
in the last quarter.
Empire Life Investments Inc. now owns 30,312 shares of the specialty chemicals
company's
stock valued at $ 4,626,000 after buying an
additional 486 shares
in the last quarter.
American International Group Inc. now owns 51,539 shares of the biopharmaceutical
company's
stock worth $ 1,607,000 after purchasing an
additional 2,255 shares
in the last quarter.
William Blair Investment Management LLC now owns 1,762,619 shares of the medical device
company's
stock worth $ 101,157,000 after purchasing an
additional 344,294 shares
in the last quarter.
Zurcher Kantonalbank Zurich Cantonalbank now owns 4,662 shares of the biopharmaceutical
company's
stock worth $ 145,000 after purchasing an
additional 2,698 shares
in the last quarter.
AXA now owns 1,911,206 shares of the medical device
company's
stock worth $ 109,684,000 after purchasing an
additional 592,275 shares
in the last quarter.
OppenheimerFunds Inc. now owns 1,495,535 shares of the medical device
company's
stock worth $ 85,829,000 after purchasing an
additional 734,325 shares
in the last quarter.
Covington Capital Management now owns 34,529 shares of the specialty chemicals
company's
stock valued at $ 5,270,000 after buying an
additional 515 shares
in the last quarter.
Others include the balance between pay, shares of
stock,
stock options,
additional benefits, and the rationale for how compensation is set, like the
companies used for comparison and whether they seem a reasonable match
in industry and size.
Crestline Management LP now owns 68,856 shares of the biopharmaceutical
company's
stock worth $ 2,147,000 after purchasing an
additional 3,437 shares
in the last quarter.
Public Employees Retirement Association of Colorado now owns 14,976 shares of the specialty chemicals
company's
stock valued at $ 2,285,000 after buying an
additional 503 shares
in the last quarter.
Swiss National Bank now owns 119,600 shares of the biopharmaceutical
company's
stock worth $ 3,729,000 after purchasing an
additional 2,800 shares
in the last quarter.
Mackenzie Financial Corp now owns 1,371,595 shares of the medical device
company's
stock worth $ 78,716,000 after purchasing an
additional 87,848 shares
in the last quarter.
If the
Company grants registration rights, information rights, rights of first offer, price - based antidilution protection, protective voting provisions or other similar rights to new investors
in a subsequent financing involving the sale of
additional series of Preferred
Stock, the
Company will use reasonable efforts to extend such rights to the Purchasers on the same basis granted to new investors.
ABOT Pakistan
Stock Exchange — April 21, 2016 It's always encouraging to see a
company improve its overall disclosure, including fees paid to the auditor, however,
in this case the
additional disclosure of tax advisory services has served to highlight the excessive non-audit fees paid to said auditor.
Investments
in stocks of small
companies involve
additional risks.
Small -
company stocks entail
additional risks, and they can fluctuate
in price more than larger
company stocks.
Valley National Advisers Inc. now owns 2,385 shares of the industrial products
company's
stock valued at $ 108,000 after purchasing an
additional 1,590 shares
in the last quarter.
MoviePass» parent
company Helios and Matheson Analytics sold
additional stock last week
in what seemed like a move to raise money for the service.
After
additional training at the Radio Institute of Chicago and two years» practical experience
in various dramatic radio programs and
stock companies, he left for New York
in 1950.
To the extent the Fund invests
in the
stocks of smaller - sized
companies, the Fund may be subject to
additional risks, including the risk that earnings and prospects of these
companies are more volatile than larger
companies.
In the instance of a
stock dividend, the
company pays out
additional shares of
stock to shareholders instead of paying cash.
A
company can issue a
stock dividend
in which
additional shares are distributed to existing shareholders, or it can issue a dividend of property.
The
company offers a Dividend Reinvestment Program (DRIP) allowing me to get my dividends
in additional stocks.
(For instance, an employee of a high - technology growth
company who receives
company stock or
stock options as a benefit might prefer not to have
additional funds invested
in the same industry.)
An
additional benefit of using dividends
in evaluating a
company is that since dividends only change once a year, they provide a much more stable point of analysis than metrics that are subject to the day - to - day fluctuations
in stock price.
As a newbie, I still spend a lot of time researching, and
in a couple of blogs I have seen references to
companies that will provide a small discount on the current
stock price when purchasing
additional shares using their DRIP program.
Each share of Class A Common
Stock issued and outstanding immediately prior to the Effective Date was converted, as of the Effective Date, into the right to receive $ 3.075 per share, less any required withholding taxes, plus a contingent right to receive an
additional pro rata cash amount if RISCORP recovers any amounts
in connection with the litigation currently pending against Zenith Insurance
Company and Arthur Andersen LLP.
Usually these payouts are made
in cash (called «cash dividends»), but sometimes
companies will also distribute
stock dividends, whereby
additional stock shares are distributed to shareholders.